KCNN4 promotes the progression of lung adenocarcinoma by activating the AKT and ERK signaling pathways

被引:12
|
作者
Xu, Ping [1 ,2 ,3 ]
Mo, Xiao [1 ,2 ,3 ]
Xia, Ruixue [7 ]
Jiang, Long [8 ]
Zhang, Chengfei [1 ,2 ,3 ]
Xu, Haojun [1 ,2 ,3 ]
Sun, Qi [1 ,2 ,3 ,9 ]
Zhou, Guoren [4 ,5 ,6 ]
Zhang, Yijie [7 ]
Wang, Yongsheng [9 ]
Xia, Hongping [1 ,2 ,3 ,4 ,5 ,6 ,7 ]
机构
[1] Nanjing Med Univ, Sch Basic Med Sci, Dept Pathol, Nanjing 211166, Jiangsu, Peoples R China
[2] Nanjing Med Univ, Sir Run Run Hosp, Nanjing 211166, Jiangsu, Peoples R China
[3] Nanjing Med Univ, Key Lab Antibody Tech, Natl Hlth Commiss, Nanjing 211166, Jiangsu, Peoples R China
[4] Nanjing Med Univ, Jiangsu Canc Hosp, Nanjing 210009, Jiangsu, Peoples R China
[5] Nanjing Med Univ, Affiliated Canc Hosp, Nanjing 210009, Jiangsu, Peoples R China
[6] Nanjing Med Univ, Jiangsu Inst Canc Res, Nanjing 210009, Jiangsu, Peoples R China
[7] Henan Univ, Huaihe Hosp, Dept Resp & Crit Care Med, Kaifeng 475000, Henan, Peoples R China
[8] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Shanghai Lung Canc Ctr, Shanghai, Peoples R China
[9] Nanjing Univ, Med Sch, Nanjing Drum Tower Hosp, Nanjing 210008, Jiangsu, Peoples R China
关键词
KCNN4; lung adenocarcinoma; AKT; ERK; proliferation; CANCER CELLS; MACROPHAGES; INHIBITION; EXPRESSION; INCREASES; PROGNOSIS; APOPTOSIS; KCA3.1;
D O I
10.3233/CBM-201045
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: Potassium channels, encoded by more than seventy genes, are cell excitability transmembrane proteins and become evident to play essential roles in tumor biology. OBJECTIVE: The deregulation of potassium channel genes has been related to cancer development and patient prognosis. The objective of this study is to understand the role of potassium channels in lung cancer. METHODS: We examined all potassium channel genes and identified that KCNN4 is the most significantly overexpressed one in lung adenocarcinoma. The role and mechanism of KCNN4 in lung adenocarcinoma were further investigated by in vitro cell and molecular assay and in vivo mouse xenograft models. RESULTS: We revealed that the silencing of KCNN4 significantly inhibits cell proliferation, migration, invasion, and tumorigenicity of lung adenocarcinoma. Further studies showed that knockdown of KCNN4 promotes cell apoptosis, induces cell cycle arrested in the S phase, and is associated with the epithelial to mesenchymal transition (EMT) process. Most importantly, we demonstrated that KCNN4 regulates the progression of lung adenocarcinoma through P13K/AKT and MEK/ERK signaling pathways. The use of inhibitors that targeted AKT and ERK also significantly inhibit the proliferation and metastasis of lung adenocarcinoma cells. CONCLUSIONS: This study investigated the function and mechanism of KCNN4 in lung adenocarcinoma. On this basis, this means that KCNN4 can be used as a tumor marker for lung adenocarcinoma and is expected to become an important target for a potential drug.
引用
收藏
页码:187 / 201
页数:15
相关论文
共 50 条
  • [21] Flotillin-1 promotes progression and dampens chemosensitivity to cisplatin in gastric cancer via ERK and AKT signaling pathways
    Wei, Jiahui
    Wang, Ruiqing
    Lu, Yiran
    He, Song
    Ding, Yu
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2022, 916
  • [22] Semaphorin 4D is a potential biomarker in pediatric leukemia and promotes leukemogenesis by activating PI3K/AKT and ERK signaling pathways
    Jiang, Hongchao
    Tang, Jiaolian
    Qiu, Lijuan
    Zhang, Zhen
    Shi, Shulan
    Xue, Li
    Kui, Liyue
    Huang, Tilong
    Nan, Weiwei
    Zhou, Bailing
    Zhao, Canchun
    Yu, Ming
    Sun, Qiangming
    [J]. ONCOLOGY REPORTS, 2021, 45 (04)
  • [23] HDGF promotes gefitinib resistance by activating the PI3K/AKT and MEK/ERK signaling pathways in non-small cell lung cancer
    Shuyan Han
    Zhihua Tian
    Huifang Tian
    Haibo Han
    Jun Zhao
    Yanna Jiao
    Chunli Wang
    Huifeng Hao
    Shan Wang
    Jialei Fu
    Dong Xue
    Hong Sun
    Pingping Li
    [J]. Cell Death Discovery, 9
  • [24] HDGF promotes gefitinib resistance by activating the PI3K/AKT and MEK/ERK signaling pathways in non-small cell lung cancer
    Han, Shuyan
    Tian, Zhihua
    Tian, Huifang
    Han, Haibo
    Zhao, Jun
    Jiao, Yanna
    Wang, Chunli
    Hao, Huifeng
    Wang, Shan
    Fu, Jialei
    Xue, Dong
    Sun, Hong
    Li, Pingping
    [J]. CELL DEATH DISCOVERY, 2023, 9 (01)
  • [25] COMP promotes pancreatic fibrosis by activating pancreatic stellate cells through CD36-ERK/AKT signaling pathways
    Wang, Yi
    Li, Hai-Tao
    Liu, Gang
    Jiang, Chuan-Shen
    Ni, Yan-Hong
    Zeng, Jing-Hui
    Lin, Xia
    Wang, Qing-Yun
    Li, Da-Zhou
    Wang, Wen
    Zeng, Xiang-Peng
    [J]. CELLULAR SIGNALLING, 2024, 118
  • [26] SAE1 promotes human glioma progression through activating AKT SUMOylation-mediated signaling pathways
    Yanfang Yang
    Ziwei Liang
    Zijing Xia
    Xixi Wang
    Yanni Ma
    Zenghua Sheng
    Qingjia Gu
    Guobo Shen
    Liangxue Zhou
    Hongxia Zhu
    Ningzhi Xu
    Shufang Liang
    [J]. Cell Communication and Signaling, 17
  • [27] SAE1 promotes human glioma progression through activating AKT SUMOylation-mediated signaling pathways
    Yang, Yanfang
    Liang, Ziwei
    Xia, Zijing
    Wang, Xixi
    Ma, Yanni
    Sheng, Zenghua
    Gu, Qingjia
    Shen, Guobo
    Zhou, Liangxue
    Zhu, Hongxia
    Xu, Ningzhi
    Liang, Shufang
    [J]. CELL COMMUNICATION AND SIGNALING, 2019, 17 (1)
  • [28] RETRACTION: lncRNA-u50535 promotes the progression of lung cancer by activating CCL20/ERK signaling
    Wei, Wei
    Zhao, Xiaoliang
    Zhu, Jianquan
    Zhang, Lianmin
    Chen, Yulong
    Zhang, Bin
    Li, Yue
    Wang, Meng
    Zhang, Zhenfa
    Wang, Changli
    [J]. ONCOLOGY REPORTS, 2024, 52 (04)
  • [29] Tropomodulin 3 promotes liver cancer progression by activating the MAPK/ERK signaling pathway
    Jin, Canguang
    Chen, Zhikang
    Shi, Wei
    Lian, Qi
    [J]. ONCOLOGY REPORTS, 2019, 41 (05) : 3060 - 3068
  • [30] TEAD4 promotes tumor development in patients with lung adenocarcinoma via ERK signaling pathway
    Gu, Chang
    Huang, Zhenyu
    Chen, Xiaojian
    Liu, Chenying
    Rocco, Gaetano
    Zhao, Shengnan
    Xie, Huikang
    Chen, Jiafei
    Dai, Chenyang
    Chen, Chang
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2020, 1866 (12):